Quick Answer
Oruka Therapeutics, Inc. reported Total Assets of $488.62 million for fiscal year 2025.
Oruka Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $488.62M | +23.4% |
| 2024 | $396.02M | +39601800.0% |
| 2024 | $1.0K | -100.0% |
| 2023 | $37.86M | -12.1% |
| 2022 | $43.09M | -21.6% |
| 2021 | $54.92M | +8.9% |
| 2020 | $50.43M | +490.8% |
| 2019 | $8.54M | +25.1% |
| 2018 | $6.83M | -44.8% |
| 2017 | $12.37M | -49.8% |
| 2016 | $24.63M | -37.8% |
| 2015 | $39.57M | +145.3% |
| 2014 | $16.13M | -5.6% |
| 2013 | $17.08M | +431.9% |
| 2012 | $3.21M | -50.6% |
| 2011 | $6.50M | -20.3% |
| 2010 | $8.16M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $509.25M | +23.0% | +42.5% |
| June 30, 2025 | $357.42M | +956.1% | -5.2% |
| March 31, 2025 | $377.11M | +927.4% | -4.8% |
| December 31, 2024 | $396.02M | +946.0% | -4.4% |
| September 30, 2024 | $414.09M | +956.8% | +1123.5% |
| June 30, 2024 | $33.84M | -17.6% | -7.8% |
| March 31, 2024 | $36.71M | -12.7% | +3670500.0% |
| January 31, 2024 | $1.0K | — | -100.0% |
- Oruka Therapeutics, Inc. showed an increase of +23.4% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, Oruka Therapeutics, Inc.’s total assets has grown by 5890.9% (from $8.16 million to $488.62 million).
- The most recent figure is from Oruka Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: